这是一篇来自已证抗体库的有关人类 TGF-乙一 (TGF-beta1) 的综述,是根据68篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合TGF-乙一 抗体。
TGF-乙一 同义词: CED; DPD1; LAP; TGFB; TGFbeta; transforming growth factor beta-1; TGF-beta-1; latency-associated peptide; prepro-transforming growth factor beta-1

安迪生物R&D
小鼠 单克隆(1D11)
  • 免疫组化-冰冻切片; 小鼠; 图 4a
安迪生物R&DTGF-乙一抗体(R&D, MAB1835)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 4a). Cell Death Dis (2018) ncbi
小鼠 单克隆(141322)
  • 其他; 人类; 图 s1
安迪生物R&DTGF-乙一抗体(R&D Systems, MAB2401)被用于被用于其他在人类样本上 (图 s1). Cell Chem Biol (2017) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 图 1c
安迪生物R&DTGF-乙一抗体(R&D, AF-246-N)被用于被用于免疫印迹在人类样本上 (图 1c). J Immunol (2017) ncbi
小鼠 单克隆(1D11)
  • 流式细胞仪; 小鼠; 图 4d
安迪生物R&DTGF-乙一抗体(R&D systems, 1D11)被用于被用于流式细胞仪在小鼠样本上 (图 4d). Nature (2016) ncbi
小鼠 单克隆(1D11)
  • 抑制或激活实验; 人类; 5 ug/ml
安迪生物R&DTGF-乙一抗体(R&D systems, MAB1835)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml. Carcinogenesis (2017) ncbi
山羊 多克隆
  • 抑制或激活实验; 人类; 图 6c
安迪生物R&DTGF-乙一抗体(R&D, AB-246-NA)被用于被用于抑制或激活实验在人类样本上 (图 6c). Oncotarget (2016) ncbi
小鼠 单克隆(1D11)
  • 抑制或激活实验; 小鼠; 10 ug/ml; 图 2b
安迪生物R&DTGF-乙一抗体(R&D Systems, 1D11)被用于被用于抑制或激活实验在小鼠样本上浓度为10 ug/ml (图 2b). J Exp Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:500
安迪生物R&DTGF-乙一抗体(R&D Systems, AB-100NA)被用于被用于免疫印迹在小鼠样本上浓度为1:500. J Clin Invest (2016) ncbi
小鼠 单克隆(9016)
  • 抑制或激活实验; 人类; 图 3c
安迪生物R&DTGF-乙一抗体(R&D Systems, 9016)被用于被用于抑制或激活实验在人类样本上 (图 3c). J Immunol (2016) ncbi
小鼠 单克隆(9016)
  • 流式细胞仪; 人类; 图 4b
安迪生物R&DTGF-乙一抗体(R&D Systems, 9016)被用于被用于流式细胞仪在人类样本上 (图 4b). Sci Rep (2016) ncbi
兔 多克隆
  • 抑制或激活实验; 小鼠; 3 mg/kg; 图 s4
安迪生物R&DTGF-乙一抗体(R&D Systems, AB-100-NA)被用于被用于抑制或激活实验在小鼠样本上浓度为3 mg/kg (图 s4). Sci Rep (2016) ncbi
小鼠 单克隆(1D11)
  • 抑制或激活实验; 人类; 图 2a
安迪生物R&DTGF-乙一抗体(R&D Systems, MAB1835)被用于被用于抑制或激活实验在人类样本上 (图 2a). J Dent Res (2016) ncbi
小鼠 单克隆(1D11)
  • 抑制或激活实验; 人类; 图 4c
安迪生物R&DTGF-乙一抗体(R&D Systems, 1D11)被用于被用于抑制或激活实验在人类样本上 (图 4c). Curr Cancer Drug Targets (2016) ncbi
小鼠 单克隆(9016)
  • 流式细胞仪; 人类; 图 1
安迪生物R&DTGF-乙一抗体(R&D Systems, 9016)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(27232)
  • 流式细胞仪; 人类; 图 6
安迪生物R&DTGF-乙一抗体(R&D, FAB2463P)被用于被用于流式细胞仪在人类样本上 (图 6). Nat Commun (2015) ncbi
安迪生物R&DTGF-乙一抗体(R&D Systems, DB100B)被用于. PLoS Med (2015) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 图 6
安迪生物R&DTGF-乙一抗体(R&D Systems, BAF246)被用于被用于免疫印迹在人类样本上 (图 6). J Biol Chem (2015) ncbi
小鼠 单克隆(27232)
  • 流式细胞仪; 人类
安迪生物R&DTGF-乙一抗体(R&D Systems, 27232)被用于被用于流式细胞仪在人类样本上. J Biol Chem (2015) ncbi
鸡 多克隆
  • 酶联免疫吸附测定; 小鼠
安迪生物R&DTGF-乙一抗体(R&D Systems, BAF240)被用于被用于酶联免疫吸附测定在小鼠样本上. J Biol Chem (2015) ncbi
山羊 多克隆
  • 免疫组化; 人类; 图 3
安迪生物R&DTGF-乙一抗体(R&D Systems, AB246NA)被用于被用于免疫组化在人类样本上 (图 3). J Histochem Cytochem (2015) ncbi
小鼠 单克隆(27232)
  • 流式细胞仪; 人类
安迪生物R&DTGF-乙一抗体(R&D Systems, 27232)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1 ug/ml
安迪生物R&DTGF-乙一抗体(R&D Systems, AB-100NA)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1 ug/ml. PLoS ONE (2014) ncbi
安迪生物R&DTGF-乙一抗体(R&D system, DB100B)被用于. Int J Med Sci (2014) ncbi
小鼠 单克隆(27232)
  • 流式细胞仪; 人类; 图 1b
安迪生物R&DTGF-乙一抗体(R&D Systems, 27232)被用于被用于流式细胞仪在人类样本上 (图 1b). Eur J Immunol (2014) ncbi
山羊 多克隆
  • 酶联免疫吸附测定; 人类
安迪生物R&DTGF-乙一抗体(R&D, AF-246-NA)被用于被用于酶联免疫吸附测定在人类样本上. PLoS ONE (2012) ncbi
艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 7d
艾博抗(上海)贸易有限公司TGF-乙一抗体(abcam, ab92486)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 7d). Kidney Int (2019) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 4c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab92486)被用于被用于免疫印迹在小鼠样本上 (图 4c). Cell Death Dis (2018) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 图 6c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab92486)被用于被用于免疫印迹在小鼠样本上 (图 6c). Basic Res Cardiol (2017) ncbi
兔 多克隆
  • 免疫组化; 大鼠; 1:400; 图 11c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab92486)被用于被用于免疫组化在大鼠样本上浓度为1:400 (图 11c). Am J Pathol (2017) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 2i
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab92486)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 2i). Nat Med (2017) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 4c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab92486)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4c). Pharmacol Rep (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2k
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab9758)被用于被用于免疫印迹在人类样本上 (图 2k). Oncotarget (2016) ncbi
小鼠 单克隆(TB21)
  • 免疫印迹; 小鼠; 1:500; 图 4
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab190503)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4). Int J Mol Med (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图 5
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab25121)被用于被用于免疫印迹在大鼠样本上 (图 5). Evid Based Complement Alternat Med (2016) ncbi
小鼠 单克隆(TB21)
  • 抑制或激活实验; 人类; 图 6
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab27969)被用于被用于抑制或激活实验在人类样本上 (图 6). Sci Rep (2016) ncbi
小鼠 单克隆(TB21)
  • 免疫印迹; 大鼠; 1:500; 图 2c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab27969)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 2c). Eur J Pharmacol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab9758)被用于被用于免疫印迹在人类样本上. J Biol Chem (2015) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 3c,5e,5f,6c
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, Ab92486)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 3c,5e,5f,6c). Lasers Surg Med (2015) ncbi
小鼠 单克隆(TB21)
  • 免疫组化; 大鼠
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab27969)被用于被用于免疫组化在大鼠样本上. Biomed Mater (2014) ncbi
兔 多克隆
  • 免疫组化-冰冻切片; 小鼠
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam, ab9758)被用于被用于免疫组化-冰冻切片在小鼠样本上 和 被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(TB21)
  • 免疫印迹; 大鼠; 1:2000
艾博抗(上海)贸易有限公司TGF-乙一抗体(Abcam plc, ab27969)被用于被用于免疫印迹在大鼠样本上浓度为1:2000. PLoS ONE (2013) ncbi
BioLegend
小鼠 单克隆(19D8)
  • 抑制或激活实验; 人类; 100 ug/ml; 图 8a
BioLegendTGF-乙一抗体(BioLegend, 19D8)被用于被用于抑制或激活实验在人类样本上浓度为100 ug/ml (图 8a). Am J Trop Med Hyg (2018) ncbi
小鼠 单克隆(TW7-28G11)
  • 流式细胞仪; 人类; 图 4c
BioLegendTGF-乙一抗体(Biolegend, 146704)被用于被用于流式细胞仪在人类样本上 (图 4c). Nature (2017) ncbi
小鼠 单克隆(TW4-6H10)
  • 流式细胞仪; 人类; 图 1c
BioLegendTGF-乙一抗体(BioLegend, TW4-6H10)被用于被用于流式细胞仪在人类样本上 (图 1c). Cell Death Dis (2016) ncbi
小鼠 单克隆(19D8)
  • 流式细胞仪; 小鼠; 图 4
BioLegendTGF-乙一抗体(BioLegend, 521705)被用于被用于流式细胞仪在小鼠样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(19D8)
BioLegendTGF-乙一抗体(BioLegend, 521703)被用于. Nat Commun (2015) ncbi
小鼠 单克隆(TW4-2F8)
  • 流式细胞仪; 人类; 表 s1
BioLegendTGF-乙一抗体(Biolegend, TW4-2F8)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(TW4-2F8)
  • 流式细胞仪; 人类; 图 2
BioLegendTGF-乙一抗体(BioLeged, TW4-2F8)被用于被用于流式细胞仪在人类样本上 (图 2). J Autoimmun (2015) ncbi
小鼠 单克隆(TW4-2F8)
  • 流式细胞仪; 人类
BioLegendTGF-乙一抗体(BioLegend, TW4-2 F8)被用于被用于流式细胞仪在人类样本上. Virol J (2014) ncbi
小鼠 单克隆(TW4-2F8)
BioLegendTGF-乙一抗体(BioLegend, TW4-2F8)被用于. Immunol Cell Biol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(500-M66)
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-65378)被用于被用于免疫印迹在人类样本上 (图 1c). BMC Cancer (2017) ncbi
小鼠 单克隆(TB21)
  • 免疫印迹; 人类; 1:1000; 图 6c
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-52893)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6c). Oncotarget (2016) ncbi
小鼠 单克隆(TB21)
  • 免疫组化-石蜡切片; 大鼠; 1:200; 图 5
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-52893)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200 (图 5). Mol Med Rep (2016) ncbi
小鼠 单克隆(TB21)
  • 免疫印迹; 人类
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz Biotechnology, sc-52893)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(3C11)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-130348)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Med Rep (2015) ncbi
小鼠 单克隆(3C11)
  • 免疫印迹; 大鼠; 图 4a
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz Biotechnology, sc-130348)被用于被用于免疫印迹在大鼠样本上 (图 4a). Mol Med Rep (2015) ncbi
小鼠 单克隆(3C11)
  • 免疫组化; 人类; 图 3c
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-130348)被用于被用于免疫组化在人类样本上 (图 3c) 和 被用于免疫印迹在人类样本上 (图 3a). Connect Tissue Res (2015) ncbi
小鼠 单克隆(3C11)
  • 免疫细胞化学; 人类
圣克鲁斯生物技术TGF-乙一抗体(Santa Cruz, sc-130348)被用于被用于免疫细胞化学在人类样本上. Colloids Surf B Biointerfaces (2014) ncbi
Bio X Cell
小鼠 单克隆(1D11.16.8)
  • 抑制或激活实验; 小鼠; 图 1l
Bio X CellTGF-乙一抗体(BioXcell, 1D11.16.8)被用于被用于抑制或激活实验在小鼠样本上 (图 1l). J Exp Med (2017) ncbi
小鼠 单克隆(1D11.16.8)
  • 抑制或激活实验; 小鼠
Bio X CellTGF-乙一抗体(BioXcell, 1D11.16.8)被用于被用于抑制或激活实验在小鼠样本上. Infect Immun (2016) ncbi
小鼠 单克隆(1D11.16.8)
  • 流式细胞仪; 小鼠; 图 5c
Bio X CellTGF-乙一抗体(Bioxcell, 1D11.16.8)被用于被用于流式细胞仪在小鼠样本上 (图 5c). Nat Commun (2014) ncbi
赛默飞世尔
鸡 多克隆
  • 免疫组化-石蜡切片; 大鼠; 图 5
赛默飞世尔TGF-乙一抗体(Thermo Fisher Scientific, PA1-9574)被用于被用于免疫组化-石蜡切片在大鼠样本上 (图 5). Naunyn Schmiedebergs Arch Pharmacol (2016) ncbi
兔 单克隆(F.888.7)
  • 免疫印迹; 人类
赛默飞世尔TGF-乙一抗体(Pierce Biotechnology, MA5-15065)被用于被用于免疫印迹在人类样本上. Acta Biomater (2014) ncbi
小鼠 单克隆(TB21)
  • 抑制或激活实验; 人类
赛默飞世尔TGF-乙一抗体(Biosource, TB21)被用于被用于抑制或激活实验在人类样本上. Microbes Infect (2007) ncbi
小鼠 单克隆(TB21)
  • 抑制或激活实验; 人类
赛默飞世尔TGF-乙一抗体(Biosource, TB21)被用于被用于抑制或激活实验在人类样本上. Infect Immun (2005) ncbi
小鼠 单克隆(TB21)
  • 抑制或激活实验; 人类; 10 ug/ml
赛默飞世尔TGF-乙一抗体(Biosource, clone TB21)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml. Am J Respir Crit Care Med (2002) ncbi
北京傲锐东源
小鼠 单克隆(OTI3B6)
  • 免疫印迹; 人类; 1:2000; 图 3d
北京傲锐东源TGF-乙一抗体(OriGene, OTI3B6)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3d). Tumour Biol (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(TB21)
  • 免疫组化; 人类; 1:100; 图 1c
伯乐(Bio-Rad)公司TGF-乙一抗体(AbD Serotec, MCA797)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1c). BMC Cancer (2015) ncbi
兔 多克隆
  • 免疫组化; 小鼠
伯乐(Bio-Rad)公司TGF-乙一抗体(Serotec, AHP1734)被用于被用于免疫组化在小鼠样本上. Acta Biomater (2015) ncbi
亚诺法生技股份有限公司
兔 多克隆
  • 抑制或激活实验; 人类
亚诺法生技股份有限公司TGF-乙一抗体(Abnova, PAB 12738)被用于被用于抑制或激活实验在人类样本上. Am J Sports Med (2017) ncbi
GeneTex
兔 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 3
  • 免疫组化-石蜡切片; 斑马鱼; 图 2
GeneTexTGF-乙一抗体(Genetex, GTX110630)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3) 和 被用于免疫组化-石蜡切片在斑马鱼样本上 (图 2). Front Pharmacol (2016) ncbi
西格玛奥德里奇
兔 多克隆
  • 免疫印迹; 大鼠
西格玛奥德里奇TGF-乙一抗体(Sigma, SAB4502954)被用于被用于免疫印迹在大鼠样本上. Int J Mol Med (2015) ncbi
文章列表
  1. HASAN A, von Websky K, Reichetzeder C, Tsuprykov O, Gaballa M, Guo J, et al. Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy. Kidney Int. 2019;95:1373-1388 pubmed 出版商
  2. Yin J, Wang Y, Chang J, Li B, Zhang J, Liu Y, et al. Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i. Cell Death Dis. 2018;9:1031 pubmed 出版商
  3. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed 出版商
  4. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  5. Wang Q, Yu Y, Zhang P, Chen Y, Li C, Chen J, et al. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Basic Res Cardiol. 2017;112:47 pubmed 出版商
  6. Ventura E, Weller M, Burghardt I. Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-? and Furin in Glioma-Initiating Cells. J Immunol. 2017;198:4569-4574 pubmed 出版商
  7. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed 出版商
  8. Manzanares M, Usui A, Campbell D, Dumur C, Maldonado G, Fausther M, et al. Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model. Am J Pathol. 2017;187:1068-1092 pubmed 出版商
  9. de la Mare J, Jurgens T, Edkins A. Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model. BMC Cancer. 2017;17:202 pubmed 出版商
  10. Dong X, Zhao B, Iacob R, Zhu J, Koksal A, Lu C, et al. Force interacts with macromolecular structure in activation of TGF-?. Nature. 2017;542:55-59 pubmed 出版商
  11. Oller J, Méndez Barbero N, Ruiz E, Villahoz S, Renard M, Canelas L, et al. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat Med. 2017;23:200-212 pubmed 出版商
  12. Miroshnychenko O, Chang W, Dragoo J. The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts: Implications for the Use of Autologous Blood Products for Muscle Regeneration. Am J Sports Med. 2017;45:945-953 pubmed 出版商
  13. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed 出版商
  14. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed 出版商
  15. Cirillo N, Hassona Y, Celentano A, Lim K, Manchella S, Parkinson E, et al. Cancer-associated fibroblasts regulate keratinocyte cell-cell adhesion via TGF-β-dependent pathways in genotype-specific oral cancer. Carcinogenesis. 2017;38:76-85 pubmed 出版商
  16. Wang Y, Han G, Guo B, Huang J. Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis. Pharmacol Rep. 2016;68:1126-1132 pubmed 出版商
  17. Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang Y, et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop. Oncotarget. 2016;7:63324-63337 pubmed 出版商
  18. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed 出版商
  19. Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prud homme G, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489-69506 pubmed 出版商
  20. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed 出版商
  21. Hou C, Wu Q, Ouyang C, Huang T. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 2016;38:713-20 pubmed 出版商
  22. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed 出版商
  23. Giusti I, Delle Monache S, Di Francesco M, Sanità P, D Ascenzo S, Gravina G, et al. From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis. Tumour Biol. 2016;37:12743-12753 pubmed
  24. Piancone F, Saresella M, Marventano I, La Rosa F, Zoppis M, Agostini S, et al. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity. Sci Rep. 2016;6:29699 pubmed 出版商
  25. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed 出版商
  26. Wei M, He W, Lu X, Ni L, Yang Y, Chen L, et al. JiaWeiDangGui Decoction Ameliorates Proteinuria and Kidney Injury in Adriamycin-Induced Rat by Blockade of TGF-?/Smad Signaling. Evid Based Complement Alternat Med. 2016;2016:5031890 pubmed 出版商
  27. Chuang H, Su H, Li C, Lin S, Yen S, Huang M, et al. The Role of Butylidenephthalide in Targeting the Microenvironment Which Contributes to Liver Fibrosis Amelioration. Front Pharmacol. 2016;7:112 pubmed 出版商
  28. Zhang M, Huang W, Bai J, Nie X, Wang W. Chymase inhibition protects diabetic rats from renal lesions. Mol Med Rep. 2016;14:121-8 pubmed 出版商
  29. Abuelezz S, Hendawy N, Osman W. Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:897-909 pubmed 出版商
  30. Wang S, Gao X, Shen G, Wang W, Li J, Zhao J, et al. Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity. Sci Rep. 2016;6:24249 pubmed 出版商
  31. Yang W, Deng Y, Hsieh Y, Wu K, Kuo M. Thrombin Activates Latent TGF?1 via Integrin ?v?1 in Gingival Fibroblasts. J Dent Res. 2016;95:939-45 pubmed 出版商
  32. Nguyen H, Kadam P, Helkin A, Cao K, Wu S, Samara G, et al. MT1-MMP Activation of TGF-? Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer. Curr Cancer Drug Targets. 2016;16:618-30 pubmed
  33. Zhao C, Zhang W, Zhao Y, Yang Y, Luo H, Ji G, et al. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Sci Rep. 2016;6:19404 pubmed 出版商
  34. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed 出版商
  35. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  36. Villegas Mendez A, Shaw T, Inkson C, Strangward P, de Souza J, Couper K. Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Infect Immun. 2016;84:34-46 pubmed 出版商
  37. Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, et al. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Med. 2015;12:e1001871 pubmed 出版商
  38. Huygens C, Liénart S, Dedobbeleer O, Stockis J, Gauthy E, Coulie P, et al. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells. J Biol Chem. 2015;290:20105-16 pubmed 出版商
  39. Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, et al. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC Cancer. 2015;15:453 pubmed 出版商
  40. Kaushansky N, Eisenstein M, Boura Halfon S, Hansen B, Nielsen C, Milo R, et al. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease. J Biol Chem. 2015;290:15260-78 pubmed 出版商
  41. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  42. Yoshiba N, Yoshiba K, Ohkura N, Takei E, Edanami N, Oda Y, et al. Correlation between Fibrillin-1 Degradation and mRNA Downregulation and Myofibroblast Differentiation in Cultured Human Dental Pulp Tissue. J Histochem Cytochem. 2015;63:438-48 pubmed 出版商
  43. Ueda K, Yoshimura K, Yamashita O, Harada T, Morikage N, Hamano K. Possible dual role of decorin in abdominal aortic aneurysm. PLoS ONE. 2015;10:e0120689 pubmed 出版商
  44. Wang Y, Nie M, Lu Y, Wang R, Li J, Yang B, et al. Fucoidan exerts protective effects against diabetic nephropathy related to spontaneous diabetes through the NF-κB signaling pathway in vivo and in vitro. Int J Mol Med. 2015;35:1067-73 pubmed 出版商
  45. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  46. Li X, Wu Y, Li X, Li D, Du J, Hu C, et al. Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis. Eur J Pharmacol. 2015;749:89-97 pubmed 出版商
  47. Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, et al. CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway. J Immunol. 2015;194:960-72 pubmed 出版商
  48. Singh K, Lovren F, Pan Y, Quan A, Ramadan A, Matkar P, et al. The essential autophagy gene ATG7 modulates organ fibrosis via regulation of endothelial-to-mesenchymal transition. J Biol Chem. 2015;290:2547-59 pubmed 出版商
  49. Leung S, Rice P, Barton J. In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis. Lasers Surg Med. 2015;47:40-9 pubmed 出版商
  50. Huang W, Li L, Tian X, Yan J, Yang X, Wang X, et al. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep. 2015;11:2569-77 pubmed 出版商
  51. Huang W, Li L, Tian X, Yan J, Yang X, Wang X, et al. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats. Mol Med Rep. 2015;11:805-14 pubmed 出版商
  52. Lopes Pacheco M, Ventura T, de Oliveira H, Monção Ribeiro L, Gutfilen B, de Souza S, et al. Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis. PLoS ONE. 2014;9:e109982 pubmed 出版商
  53. Moore L, Sawyer A, Charokopos A, Skokos E, Kyriakides T. Loss of monocyte chemoattractant protein-1 alters macrophage polarization and reduces NFκB activation in the foreign body response. Acta Biomater. 2015;11:37-47 pubmed 出版商
  54. Zhang X, Ma Y, You T, Tian X, Zhang H, Zhu Q, et al. Roles of TGF-β/Smad signaling pathway in pathogenesis and development of gluteal muscle contracture. Connect Tissue Res. 2015;56:9-17 pubmed 出版商
  55. Rothan H, Djordjevic I, Bahrani H, Paydar M, Ibrahim F, Abd Rahmanh N, et al. Three-dimensional culture environment increases the efficacy of platelet rich plasma releasate in prompting skin fibroblast differentiation and extracellular matrix formation. Int J Med Sci. 2014;11:1029-38 pubmed 出版商
  56. McLane J, Rivet C, Gilbert R, Ligon L. A biomaterial model of tumor stromal microenvironment promotes mesenchymal morphology but not epithelial to mesenchymal transition in epithelial cells. Acta Biomater. 2014;10:4811-4821 pubmed 出版商
  57. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed 出版商
  58. Sueur C, Lupo J, Mas P, Morand P, Boyer V. Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line. Virol J. 2014;11:94 pubmed 出版商
  59. Bedke T, Iannitti R, De Luca A, Giovannini G, Fallarino F, Berges C, et al. Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. Immunol Cell Biol. 2014;92:659-70 pubmed 出版商
  60. León B, Bradley J, Lund F, Randall T, Ballesteros Tato A. FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability. Nat Commun. 2014;5:3495 pubmed 出版商
  61. Yan J, Chen Y, Yuan Q, Wang X, Yu S, Qiu W, et al. Comparison of the effects of Mg-6Zn and Ti-3Al-2.5V alloys on TGF-?/TNF-?/VEGF/b-FGF in the healing of the intestinal tract in vivo. Biomed Mater. 2014;9:025011 pubmed 出版商
  62. Du M, Liang H, Mou C, Li X, Sun J, Zhuang Y, et al. Regulation of human mesenchymal stem cells differentiation into chondrocytes in extracellular matrix-based hydrogel scaffolds. Colloids Surf B Biointerfaces. 2014;114:316-23 pubmed 出版商
  63. Zeng L, Wang G, Ummarino D, Margariti A, Xu Q, Xiao Q, et al. Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor ?2. J Biol Chem. 2013;288:31853-66 pubmed 出版商
  64. Gay Jordi G, Guash E, Benito B, Brugada J, Nattel S, Mont L, et al. Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PLoS ONE. 2013;8:e55427 pubmed 出版商
  65. Kaur J, Reinhardt D. Immobilized metal affinity chromatography co-purifies TGF-?1 with histidine-tagged recombinant extracellular proteins. PLoS ONE. 2012;7:e48629 pubmed 出版商
  66. Bourreau E, Ronet C, Couppie P, Sainte Marie D, Tacchini Cottier F, Launois P. IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect. 2007;9:1034-41 pubmed
  67. Kariminia A, Bourreau E, Pascalis H, Couppie P, Sainte Marie D, Tacchini Cottier F, et al. Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun. 2005;73:5908-14 pubmed
  68. Hamacher J, Lucas R, Lijnen H, Buschke S, Dunant Y, Wendel A, et al. Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166:651-6 pubmed